The neurobiology of cell death in glaucoma

Eye (Basingstoke)

Volumn 21, Issue , 2007, Pages S11-S14

  Vrabec, J P ^a   Levin, L A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Glaucoma; Optic neuropathy; Oxonal injury; Retinal ganglion cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CILIARY NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; AXONAL INJURY; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; GLAUCOMA; HUMAN; INHIBITION KINETICS; LATERAL GENICULATE NUCLEUS; NERVE FIBER TRANSPORT; NEUROBIOLOGY; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; VISUAL CORTEX; VISUAL FIELD DEFECT;

EID: 37749010317     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702880     Document Type: Article

References (29)

1. The AGIS Investigators. The advanced glaucoma intervention study, 6: effect of cataract on visual field and visual acuity. The AGIS Investigators. Arch Ophthalmol 2000; 118: 1639-1652.
2. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994; 15: 299-325.
3. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126: 498-505.
4. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am I Ophthalmol 1998; 126: 487-497.
5. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943-1953.
6. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-1279.
7. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994; 14(7): 4368-4374.
8. Lieven CJ, Hoegger MJ, Schlieve CR, Levin LA. Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest Ophthalmol Vis Sci 2006; 47(4): 1477-1485.
9. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 1979; 86(10): 1803-1830.
10. Boden C, Sample PA, Boehm AG, Vasile C, Akinepalli R, Weinreb RN. The structure-function relationship in eyes with glaucomatous visual field loss that crosses the horizontal meridian. Arch Ophthalmol 2002; 120: 907-912.
11. Levin LA. Relevance of the site of injury of glaucoma to neuroprotective strategies. Suro Ophthalmol 2001; 45(Suppl 3): S243-S249. discussion S273-S276.
12. Yucel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000; 118(3): 378-384.
13. Malpeli JG, Lee D, Baker FH. Laminar and retinotopic organization of the macaque lateral geniculate nucleus: magnocellular and parvocellular magnification functions. J Comp Neurol 1996; 375(3): 363-377.
14. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 1995; 15(4): 805-819.
15. Nickells RW. Retinal ganglion cell death in glaucoma: The how, the why, and the maybe. J Glaucoma 1996; 5(5): 345-356.
16. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977; 16(5): 426-441.
17. Johnson EC, Deppmeier LMH, Wentzien SKF, Hsu I, Morrison JC. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000; 41: 431-442.
18. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 764-774.
19. Levin LA. Relevance of the site of injury of glaucoma to neuroprotective strategies. Suro Ophthalmol 2001; 45: S243-S249.
20. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997; 115(8): 1031-1035.
21. Okisaka S, Murakami A, Mizukawa A, Ito J. Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn I Ophthalmol 1997; 41(2): 84-88.
22. Tuulonen A, Airaksinen PJ. Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression. Am J Ophthalmol 1991; 111(4): 485-490.
23. Pernet V, Hauswirth WW, Di Polo A. Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured CNS neurons in vivo. I Neurochem 2005; 93: 72-83.
24. Cellerino A, Kohler K. Brain-derived neurotrophic factor/neurotrophin-4 receptor TrkB is localised on ganglion cells and dopaminergic amacrine cells in the vertebrate retina. I Comp Neurol 1997; 386(1): 149-160.
25. Herzog KH, von Bartheld CS. Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J Neurosci 1998; 18(8): 2891-2906.
26. Perez MT, Caminos E. Expression of brain-derived neurotrophic factor and of its functional receptor in neonatal and adult rat retina. Neurosci Lett 1995; 183(1-2): 96-99.
27. Di Polo A, Aigner LJ, Dunn RJ, Bray CM, Aguayo AJ. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 1998; 95(7): 3978-3983.
28. Meyer-Franke A, Wilkinson GA, Kruttgen A, Hu M, Monro E, Hanson MG et al. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 1998; 21: 681-693.
29. Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat Neurosci 2001; 4: 981-988.